:: January 2012

Welcome to our Monthly Online Newsletter!

View all Treatment articles in our Treatment Report . The most recent articles are listed on top (not in alphabetical order). Click on the Topic on our home page and then the subtopic - Treatment Report. Stay updated on drugs and their side effects, and various other treatments, including exercise, nutrition, and supplements.

Highlighted Articles

Our Highlighted Articles are now being included in our Weekly Featured Articles site. If you have not already signed up for our Alerts newsletter which links to this site, please do so at our sign up page. Stay current and save time. Free access to our Weekly Featured Articles and Weekly Featured Brain Articles.

Clinical Guidelines

AHRQ - Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility (2005)

American Society of Clinical Oncology (ASCO) Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: Guideline Summary (2006)

American Society of Clinical Oncology (ASCO) Patient Guide: Sentinel Lymph Node Biopsy in Early Stage Breast Cancer (2005)

ASCO Patient Guide: HER2 Testing for Breast Cancer (2006)

ESMO - Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC) (2005)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer (2005)

National Comprehensive Cancer Network (NCCN) Breast Cancer Guideline, Version 1.2007

NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis (2008)

NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian (2007)

NCCN - Breast Cancer Treatment Guidelines for Patients ? Version VII, December 2005

NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction (2008)

NGC - AHRQ - Understanding Breast Cancer Treatment: A Guide for Patients (2005)

NGC - American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. (2005)

NGC - American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor?positive breast cancer: status report 2004. (2004)

NGC - Breast cancer. (2004)

NGC - Breast cancer. (2005)

NGC - Breast cancer treatment. (2004)

NGC - Breast cancer treatment. (2005)

NGC - Breast masses. (2005)

NGC - Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. (2004)

NGC - Common breast problems. (2007)

NGC - Diagnosis of breast disease. (2005)

NGC - Diagnostic imaging in breast cancer. (2006)

NGC - GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER

NGC - Management of breast cancer in women. A national clinical guideline. (2005)

NGC - Palpable breast masses. (2006)

NGC - Procedure guideline for breast scintigraphy. (2004)

NGC - SCREENING FOR BREAST CANCER

NGC - Stage 1 breast carcinoma. (2006)

NGC - The role of taxanes in neoadjuvant chemotherapy for women with non-metastatic breast cancer. (2004)

NGC - The use of magnetic resonance imaging of the breast (MRIB) for screening of women at high risk of breast cancer. (2004)

NGC - Use of bisphosphonates in women with breast cancer. (2004)

NICE - Familial breast cancer (2004)

Internet Sites

Featured site

Breast Cancer

CDC - Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion: National Breast and Cervical Cancer Early Detection Program: Program Contacts

Environment and Breast Cancer: Science Review

International Breast Cancer Screening Network

National Comprehensive Cancer Network

NCI - Antiperspirants/Deodorants and Breast Cancer: Questions and Answers

NCI - Breast Cancer

NCI - Breast Cancer Diagnosis

NCI - Breast Cancer (PDQŽ): Prevention

NCI - Breast Cancer (PDQŽ): Screening

NCI - Breast Cancer (PDQ ®): Treatment

NCI - Breast Cancer (PDQ ®): Treatment (Health Professional Version)

NCI - Estimating Breast Cancer Risk: Questions and Answers

NCI - General Information About Breast Cancer - Treatment

NCI - Progress in Addressing Breast Cancer Rates in Marin County (News 2003)

NCI - What is screening?

NCI - What you need to know about breast cancer: Background

NIH - Breast Cancer

NIH - Breast Cancer Resources

NIH - Breast Cancer Tutorial

NIH - Breast Diseases

NIH - Male Breast Cancer

NIH - Mammography

NIH - Medical Encyclopedia Breast cancer

NIH - Paclitaxel

Related Topics - Highlighted Articles

Menopause

Postmenopausal breast cancer risk and cumulative number of menstrual cycles. (Cancer Epidemiol Biomarkers Prev. 2005) "CONCLUSION: Among women who underwent natural menopause, a higher number of menstrual cycles in lifetime, reflecting a longer exposure to endogenous estrogens, is associated with an increased breast cancer risk."

Environmental Health

Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. (Cancer Epidemiol Biomarkers Prev. 2005) "Polycyclic aromatic hydrocarbons (PAH) are ubiquitous in the environment. We hypothesized that early life exposure to PAHs may have particular importance in the etiology of breast cancer. ? Our study suggests that exposure in early life to high levels of PAHs may increase the risk of postmenopausal breast cancer; however, other confounders related to geography cannot be ruled out."

In this newsletter:

Diagnosis, Imaging, and Screening
General Information
Risk Factors
Risk Reduction

	Diagnosis, Imaging, and Screening
Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? No Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? Yes Possible Net Harms of Breast Cancer Screening The Canadian Breast Cancer Screening Guidelines Are Wrong

	General Information
Does Deodorant Ingredient Affect Breast Cancer Risk? For several years, researchers have studied a possible link between substances called parabens -- widely used as a germ-fighting preservative in cosmetics such as deodorant/antiperspirants -- and breast cancer. Investigators have learned that parabens, also found in some drugs and food products, can mimic weakly the action of the female hormone estrogen -- an established risk factor for breast cancer. And the fact that a disproportionate number of breast tumors occur nearer the underarm also had scientists wondering. But now, British researchers who examined breast tissue samples from 40 women who had mastectomies have found that traces of parabens are widespread in tissues, even in the seven women who said they'd never used underarm products. Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study. (Breast Cancer Res Treat. 2012)

	Risk Factors
Boston Lawsuit Claims DES-Breast Cancer Link IOM Issues Report on Breast Cancer and the Environment

	Risk Reduction